Status:
COMPLETED
Incidence and Management of Driveline Infection in Patients with CH-VAD
Lead Sponsor:
China National Center for Cardiovascular Diseases
Collaborating Sponsors:
Wuhan Asia Heart Hospital
Sichuan Provincial People's Hospital
Conditions:
Driveline Infection
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to learn about the incidence of the Driveline Infection of a novel full-magnetically levitated left ventricular assist device with a new design of driveline. T...
Detailed Description
1. Background: Driveline infection (DLI) is a major complication of left ventricular assist devices (LVADs) and is associated with significant morbidity and mortality. The CH-VAD is a novel, fully mag...
Eligibility Criteria
Inclusion
- Patients who received CH-VAD implantations for advanced heart failure between June 2017 and October 2024.
Exclusion
- No specific exclusion criteria
Key Trial Info
Start Date :
June 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2024
Estimated Enrollment :
181 Patients enrolled
Trial Details
Trial ID
NCT06878456
Start Date
June 1 2017
End Date
October 31 2024
Last Update
March 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fuwai Hospital
Beijing, Beijing Municipality, China